Avanos Medical (AVNS) News Today

Avanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Wednesday, July 31, Zacks reports.

Jupiter Asset Management Ltd. lowered its holdings in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 64.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 53,078 shares of the company's st

BNP Paribas Financial Markets lifted its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 314.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,583 shares of the company's stock a

Foundry Partners LLC lessened its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 56.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 163,255 shares of the company's stock after selling 207,774 shares duri

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Research analysts at Zacks Research raised their Q1 2026 earnings estimates for shares of Avanos Medical in a research report issued on Monday, July 15th. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.49 pe

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Stock analysts at Zacks Research dropped their Q4 2025 earnings per share estimates for shares of Avanos Medical in a research report issued on Monday, July 15th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per s

Heartland Advisors Inc. cut its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 59.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 159,351 shares of the company's stock after selling 231,740 shares during the period. Heartlan

Vanguard Group Inc. reduced its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 1.0% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,417,952 shares of the company's stock after selling 56,456 shares during the quarter. Vanguard Group Inc. own

Tributary Capital Management LLC raised its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 7.5% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 742,455 shares of the company's stock after purchasing an additional 51,865 shares during the p

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,150,000 shares, a growth of 9.5% from the May 31st total of 1,050,000 shares. Based on an average trading volume of 200,200 shares, the days-to-cover ratio is currently 5.7 days. Currently, 2.6% of the shares of the stock are short sold.

Avanos Medical (NYSE:AVNS) Shares Down 3.6%

Westwood Holdings Group Inc. lifted its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,151,091 shares of the company's stock after buying an additional 41,8

Norges Bank bought a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 312,790 shares of the company's stock, valued at approximately $7,016,000. Norges Bank ow

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Avanos Medical in a research note issued to investors on Tuesday, June 4th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.30 per share f

Campbell & CO Investment Adviser LLC acquired a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 46,369 shares of the company's stock, valued at approxima

Alberta Investment Management Corp boosted its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 16.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 413,418 shares of the company's stock after purchasing an

Dimensional Fund Advisors LP lessened its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,854,235 shares of the company's stock

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of Avanos Medical in a research report issued on Thursday, May 23rd. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of $

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Analysts at Zacks Research dropped their Q4 2024 earnings per share estimates for shares of Avanos Medical in a research note issued to investors on Thursday, May 23rd. Zacks Research analyst D. Dey now anticipates that the company will post earnin

Paradice Investment Management LLC lessened its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 27.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,653,312 shares of the company's s

Heartland Advisors Inc. trimmed its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 31.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 391,091 shares of the company's stock after selling 182,004 shares during the period. Heartland A

JMP Securities reissued a "market perform" rating on shares of Avanos Medical in a research note on Tuesday.

StockNews.com downgraded shares of Avanos Medical from a "buy" rating to a "hold" rating in a research report on Friday.

Avanos Medical (NYSE:AVNS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.300-1.450 for the period, compared to the consensus estimate of 1.380. The company also issued revenue guidance of $685.0 millionillion-$705.0 millionillion, compared to the consensus estimate of $691.0 millionillion.

Avanos Medical (NYSE:AVNS) updated its FY24 earnings guidance. The company provided EPS guidance of $1.30-1.45 for the period, compared to the consensus estimate of $1.38. The company also issued revenue guidance of $685-705 millionillion, compared to the consensus estimate of $691.07 millionillion.

Avanos Medical (NYSE:AVNS) will be releasing earnings on Thursday, May 2, Yahoo Finance reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589745)

Foundry Partners LLC increased its holdings in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 74.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 371,029 shares of the company's stock after buying an additional

Kestrel Investment Management Corp purchased a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 145,550 shares of the company's stoc

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) CFO Michael Greiner sold 8,000 shares of the firm's stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total value of $152,960.00. Following the sale, the chief financial officer now owns 151,495 shares of the company's stock, valued at $2,896,584.40. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Zacks Research reduced their Q2 2024 EPS estimates for shares of Avanos Medical in a research report issued to clients and investors on Thursday, March 7th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share

Charles Schwab Investment Management Inc. lifted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 6.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,442 shares of the co

Avanos Medical (NYSE:AVNS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.300-1.450 for the period.